+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodiagnostics Market by Product Type, Application, End User, Technology - Global Forecast to 2030- Product Image
Neurodiagnostics Market by Product Type, Application, End User, Technology - Global Forecast to 2030- Product Image
Sale

Neurodiagnostics Market by Product Type, Application, End User, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5014094
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neurodiagnostics market is rapidly evolving as advancements in imaging, monitoring, and data analytics transform how neurological conditions are detected and managed. Senior leaders now face new opportunities and operational challenges as innovation accelerates and healthcare delivery models adapt.

Market Snapshot: Neurodiagnostics Market Size and Growth

The Neurodiagnostics Market grew from USD 7.97 billion in 2024 to USD 8.70 billion in 2025. It is expected to continue growing at a CAGR of 8.75%, reaching USD 13.19 billion by 2030. This upward trajectory is driven by expanding clinical adoption, investments in early detection capabilities, and the integration of advanced diagnostic technologies across key markets. Ongoing demand for more rapid, precise neurological assessments is reshaping product portfolios and market strategies globally.

Scope & Segmentation

  • Product Types: Computed tomography, electroencephalography (including ambulatory, routine, sleep, and video EEG), electromyography, evoked potential (brainstem auditory, somatosensory, and visual), magnetic resonance imaging, magnetoencephalography, and positron emission tomography.
  • Applications: Alzheimer’s disease (including Lewy body and vascular dementia), brain tumor, epilepsy (focal and generalized), multiple sclerosis, stroke (hemorrhagic and ischemic), and trauma.
  • End Users: Ambulatory clinics (neurology clinics, outpatient rehabilitation centers), diagnostic centers (hospital-owned and independent), home care, hospitals (general and specialty clinics), and research institutes.
  • Technologies: Invasive modalities (depth electrode monitoring, electrocorticography), noninvasive solutions (electrophysiology, imaging modalities).
  • Regions Covered: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (spanning the UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Coverage: Siemens Healthineers AG, GE Healthcare Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Hitachi Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Cadwell Laboratories Inc., NeuroLogica Corporation.

Key Takeaways for Decision-Makers

  • Market expansion is fueled by the transition to decentralized care and demand for portable, patient-friendly neurodiagnostics solutions. Organizations are leveraging ambulatory EEG and home-based monitoring to optimize detection and management of neurological events.
  • Technological convergence—especially combining multimodal imaging with electrophysiology and leveraging artificial intelligence—gives clinicians more reliable, rapid insights, informing both acute and preventive care strategies.
  • Rapid adoption of both invasive and noninvasive technologies allows providers to tailor diagnostics to specific case needs, from intraoperative monitoring to outpatient neurological screening.
  • Regional strategies require adaptation to local reimbursement models, infrastructure maturity, and disease prevalence, with Asia-Pacific and emerging markets accelerating investment in scalable, cost-effective solutions.
  • Strategic collaborations—between device manufacturers, software partners, and healthcare providers—are accelerating the commercialization of innovations, particularly those supporting data-driven diagnostics and integrated care pathways.

Tariff Impact: U.S. Supply Chain and Market Adaptation

The implementation of U.S. tariffs in 2025 has affected neurodiagnostics equipment manufacturing and procurement. Increased costs for imported components have driven some companies to reassess sourcing and speed up localization of critical device production. Healthcare providers are engaging in more strategic negotiations, considering leasing and service-based models to control costs. Accelerated regulatory review for domestically produced devices has enabled new entrants to innovate under favorable conditions, while local partnerships have intensified to maintain competitiveness.

Methodology & Data Sources

This report employs a robust methodology integrating primary and secondary research. In-depth interviews with clinicians and administrators, proprietary surveys, and reviews of clinical trial registries, regulatory filings, and trade association reports underlie data analysis. Findings were validated with subject matter experts and subjected to thorough data triangulation.

Why This Report Matters

  • Delivers actionable insights into market segmentation, technology advancement, and evolving clinical workflows to support board-level strategy decisions.
  • Highlights risks and opportunities associated with shifting regulatory landscapes and supply chain dynamics, enabling more agile operational planning.
  • Provides an evidence-based foundation for quantifying opportunities as care settings diversify and new decision-making paradigms emerge in neurodiagnostics.

Conclusion

The neurodiagnostics market is entering a new era defined by technological integration and responsive business strategies. Decision-makers equipped with timely, comprehensive intelligence can capture emerging opportunities and foster innovation as regional and competitive dynamics continue to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurodiagnostics Market, by Product Type
8.1. Introduction
8.2. Computed Tomography
8.3. Electroencephalography
8.3.1. Ambulatory Electroencephalography
8.3.2. Routine Electroencephalography
8.3.3. Sleep Electroencephalography
8.3.4. Video Electroencephalography
8.4. Electromyography
8.5. Evoked Potential
8.5.1. Brainstem Auditory Evoked Potential
8.5.2. Somatosensory Evoked Potential
8.5.3. Visual Evoked Potential
8.6. Magnetic Resonance Imaging
8.7. Magnetoencephalography
8.8. Positron Emission Tomography
9. Neurodiagnostics Market, by Application
9.1. Introduction
9.2. Alzheimer's Disease
9.2.1. Lewy Body Dementia
9.2.2. Vascular Dementia
9.3. Brain Tumor
9.4. Epilepsy
9.4.1. Focal Epilepsy
9.4.2. Generalized Epilepsy
9.5. Multiple Sclerosis
9.6. Stroke
9.6.1. Hemorrhagic Stroke
9.6.2. Ischemic Stroke
9.7. Trauma
10. Neurodiagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Clinics
10.2.1. Neurology Clinics
10.2.2. Outpatient Rehabilitation Centers
10.3. Diagnostic Centers
10.3.1. Hospital Owned Diagnostic Centers
10.3.2. Independent Diagnostic Centers
10.4. Home Care
10.5. Hospitals
10.5.1. General Hospitals
10.5.2. Specialty Clinics
10.6. Research Institutes
11. Neurodiagnostics Market, by Technology
11.1. Introduction
11.2. Invasive
11.2.1. Depth Electrode Monitoring
11.2.2. Electrocorticography
11.3. Noninvasive
11.3.1. Electrophysiology
11.3.2. Imaging Modalities
12. Americas Neurodiagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurodiagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurodiagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Siemens Healthineers AG
15.3.2. GE Healthcare Inc.
15.3.3. Koninklijke Philips N.V.
15.3.4. Canon Medical Systems Corporation
15.3.5. Fujifilm Holdings Corporation
15.3.6. Hitachi, Ltd.
15.3.7. Natus Medical Incorporated
15.3.8. Nihon Kohden Corporation
15.3.9. Cadwell Laboratories, Inc.
15.3.10. NeuroLogica Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEURODIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. NEURODIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. NEURODIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEURODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ROUTINE ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VIDEO ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAINSTEM AUDITORY EVOKED POTENTIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOMATOSENSORY EVOKED POTENTIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VISUAL EVOKED POTENTIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY LEWY BODY DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VASCULAR DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY FOCAL EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERALIZED EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL OWNED DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEPTH ELECTRODE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROPHYSIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY IMAGING MODALITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. CANADA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 95. CANADA NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 96. CANADA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 98. CANADA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 99. CANADA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 100. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. CANADA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 102. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 103. CANADA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. CANADA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 106. CANADA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 110. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 180. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 181. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 184. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 191. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 192. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 194. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 195. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 197. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 198. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 220. ITALY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 222. ITALY NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 223. ITALY NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 225. ITALY NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 226. ITALY NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 227. ITALY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. ITALY NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 229. ITALY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 230. ITALY NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. ITALY NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. ITALY NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 233. ITALY NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 234. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 236. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 237. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 239. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 240. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 241. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 247. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 290. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 292. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 293. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 295. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 296. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 297. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 299. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 300. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 303. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 318. QATAR NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. QATAR NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 320. QATAR NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 321. QATAR NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. QATAR NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 323. QATAR NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 324. QATAR NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 325. QATAR NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. QATAR NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 327. QATAR NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 328. QATAR NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 329. QATAR NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. QATAR NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 331. QATAR NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 332. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 334. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTENTIAL, 2018-2030 (USD MILLION)
TABLE 335. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2030 (USD MILLION)
TABLE 337. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 338. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 339. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2030 (USD MILLION)
TABLE 341. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 342. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 343. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 344. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 345. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2030 (USD MILLION)
TABLE 346. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 348. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY EVOKED POTEN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neurodiagnostics market report include:
  • Siemens Healthineers AG
  • GE Healthcare Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Cadwell Laboratories, Inc.
  • NeuroLogica Corporation

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.19 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Neurodiagnostics Market Report 2025 - Product Image

Neurodiagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Neurodiagnostic and Monitoring Devices Market Report and Forecast 2024-2032 - Product Image

Neurodiagnostic and Monitoring Devices Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Neurodiagnostic and Monitoring Devices Patent Landscape Report - Product Image

Neurodiagnostic and Monitoring Devices Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From

About the Neurodiagnostics Market

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases. The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market. Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.